Product Information
TIMOLOL 0.5% GFS GEL-SOLUTION is a generic product labeled by Sandoz Inc., priced at $8.3020 per ML under NDC 61314022505. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 21, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/mL
Manufacturer
Sandoz Inc.NDC
61314022505
Classification
Generic
Dosage Form
SOLUTION, GEL FORMING / DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
New Drug (NDA)
FDA Application
NDA020963FDA Approved
10/21/1998
TE Code
AB
On Market Since
12/24/1998
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL 0.5% GFS GEL-SOLUTION has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 21.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.3020 per ML |
|---|---|
| All-time high | $38.8553 (May 12, 2021) |
| All-time low | $6.8252 (Nov 28, 2013) |
| 52-week high | $13.9013 |
| 52-week low | $8.3020 |
| Median price | $20.4141 |
| Average price | $21.1093 |
| Largest weekly change | +113.6% (Jun 18, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the timolol maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
timolol maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIMOLOL 0.5% GFS GEL-SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL 0.5% GFS GEL-SOLUTION, manufactured by Sandoz Inc., is $8.3020 per ML (NDC 61314022505), effective Sep 30, 2026.
How has the price of TIMOLOL 0.5% GFS GEL-SOLUTION changed over time?
Over the history we have for it, the NADAC for TIMOLOL 0.5% GFS GEL-SOLUTION has risen 21.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TIMOLOL 0.5% GFS GEL-SOLUTION?
Since Nov 28, 2013, the NADAC for TIMOLOL 0.5% GFS GEL-SOLUTION has ranged from a low of $6.8252 (Nov 28, 2013) to a high of $38.8553 (May 12, 2021), with a median of $20.4141 per ML.
Are there cheaper alternatives to TIMOLOL 0.5% GFS GEL-SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of TIMOLOL 0.5% GFS GEL-SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TIMOLOL 0.5% GFS GEL-SOLUTION?
TIMOLOL 0.5% GFS GEL-SOLUTION (NDC 61314022505) is labeled by Sandoz Inc., and CMS classifies it as a generic product.